Evidence map›Paper›PMID 36198605›Full record

ArticleInternal medicine (Tokyo, Japan)2022

SARS-CoV-2 Infection upon Leaving the Tokyo 2020 Olympic and Paralympic Games.

Mitsuyoshi Urashima, Hiroyuki Takao, Teppei Sakano, Kohei Takeshita, Masaki Yoshida, Yasushi Nakazawa, Makoto Kawai, Yuichi Murayama

Open access · diamondAbstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mitsuyoshi UrashimaDivision of Molecular Epidemiology, the Jikei University School of Medicine, Japan.
Hiroyuki TakaoDivision of Innovation for Medical Information Technology, the Jikei University School of Medicine, Japan.
Teppei SakanoDivision of Innovation for Medical Information Technology, the Jikei University School of Medicine, Japan.
Kohei TakeshitaDivision of Innovation for Medical Information Technology, the Jikei University School of Medicine, Japan.
Masaki YoshidaDepartment of Infectious Diseases and Infection Control, the Jikei University School of Medicine, Japan.
Yasushi NakazawaDepartment of Infectious Diseases and Infection Control, the Jikei University School of Medicine, Japan.
Makoto KawaiDivision of Cardiology, Department of Internal Medicine, the Jikei University School of Medicine, Japan.
Yuichi MurayamaDivision of Innovation for Medical Information Technology, the Jikei University School of Medicine, Japan.
Jikei University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Just before the Tokyo 2020 Olympic and Paralympic Games in Japan, the number of people infected with coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), started to increase at an unprecedented rate. This study investigated the effectiveness of vaccines in large-scale sporting events under difficult circumstances, such as during adherence to a bubble system and confinement inside the Olympic/Paralympic Village. Methods In collaboration with medical clinics inside and outside the Village, a prospective cohort study was conducted among overseas participants using the results of polymerase chain reaction (PCR) tests for SARS-CoV-2 upon leaving Japan. Results A total of 12,072 foreign participants were enrolled, 13 (0.11%) of whom had a positive PCR test result. None of these cases were broadcasters or members of the press, were tested outside the Olympic Village, or had a history of COVID-19 infection. The effectiveness of full vaccination and vaccination at least once (≥14 days ago) was 74% [95% confidence interval (CI): 6-93%] and 81% (95% CI: 30-95%), respectively. Three breakthrough infections with the Delta variant were observed in 6,485 fully vaccinated participants (0.05%). The positivity rate was 0.09% among adherents to the bubble system and 0.28% among non-adherents, but this difference was not significant. Conclusion These findings indicate that even huge sporting events such as the Olympic and Paralympic Games can proceed while pandemics are ongoing in the host country by combining countermeasures such as vaccination, frequent testing, social distancing, and adherence to a bubble system.

Indexed as

COVID-19SARS-CoV-2HumansProspective StudiesTokyobubble systemCOVID-19Olympic GamesPCRpersonal health record appSARS-CoV-2

Identifiers

PMID36198605
PMCPMC9841093
OpenAlexW4301367408

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.